share_log

Alzamend Neuro Files Investigational New Drug Application With FDA for Dementia Treatment ALZN002

Alzamend Neuro Files Investigational New Drug Application With FDA for Dementia Treatment ALZN002

Alzamend Neuro向美国食品药品管理局提交了治疗痴呆症的研究性新药申请 ALZN002
MT Newswires ·  2022/09/29 11:03

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发